Neuralace is Blackrock Neurotech's next-generation BCI platform featuring over 10,000 channels on a flexible, lace-structured chip. Designed to capture neural data at a magnitude far greater than existing electrode arrays, Neuralace aims to enable an exponential increase in BCI capabilities, potentially restoring vision and memory, treating mental health conditions, and creating more seamless brain-computer interfaces. The flexible form factor is intended to improve long-term biocompatibility compared to rigid arrays.
This device does not have a current FDA designation. It may be a research tool, preclinical device, or consumer product not subject to FDA medical device regulation.
FDA Device Regulatory Guidance ↗